A groundbreaking collaboration between two Caribbean health organizations is set to transform diagnostic and treatment pathways for life-threatening conditions including cancer across Saint Lucia, with ambitions to expand access across the Eastern Caribbean. Starting this week, the partnership between CariGenetics Saint Lucia and Lab Services & Consultations will bring cutting-edge genetic testing, advanced cancer diagnostics, and genomic sequencing services within local reach for patients who previously had to travel overseas to access these tools.
For oncologists and clinical care teams, the new access to specialized tumour profiling and tissue analysis marks a major shift in how cancer care is delivered. Instead of relying on generalized treatment protocols, clinicians can now tailor therapies to the unique genetic makeup of each patient’s condition, dramatically improving the odds of effective outcomes. Dr. Stephen King, laboratory director at Lab Services & Consultations, emphasized that immunohistochemistry and tumour genetic testing are what separate one-size-fits-all care from truly personalized, targeted medicine that delivers better results for patients.
Beyond cancer care, the collaboration expands local access to preventative genetic testing as well. Saint Lucians can now access testing to understand their inherited risk of chronic disease, learn how their body will respond to common medications, and gather actionable genetic data to inform long-term healthcare decision-making, all without leaving the country.
The initiative also carries broader public health benefits for the island nation. Building local sequencing capacity strengthens Saint Lucia’s ability to conduct widespread disease surveillance, track trends in antibiotic resistance, and boost national preparedness to respond to emerging public health threats, from new pathogen outbreaks to evolving chronic disease patterns.
Devy Frederick, CEO of CariGenetics Saint Lucia, noted that expanding access to new testing services is only the first goal of the partnership. A core priority is integrating these new diagnostic tools directly into local clinical care pathways to ensure they actually translate into tangible improvements for patient outcomes. “The aim of this partnership therefore is not only to introduce new testing services but to ensure that they are properly connected to clinical care,” Frederick explained.
While services are launching first in Saint Lucia, both organizations frame the collaboration as a stepping stone for a wider regional expansion across the Organisation of Eastern Caribbean States (OECS), working to close the gap in access to advanced diagnostic medicine across small island nations.
OECS Director General Dr. Didacus Jules hailed the partnership as far more than a standard commercial collaboration. “It is an act of intellectual sovereignty, a declaration that the Eastern Caribbean has the ambition, the talent, and now the infrastructure to participate meaningfully in the future of medicine,” Jules said.